Severity
Moderate
FDA Devices recall · Reported April 27, 2022
False positive or false negative G12C (12CYS) mutation result for the KRAS Mutation Status resulting from Flags/Warnings may invalidate the result for one or more individual mutat…
Qiagen Sciences LLC recalled therascreen KRAS RGQ PCR Kit (24) REF 874052 (Japan IVD, not released in the USA) - a moderate-severity action.
therascreen KRAS RGQ PCR Kit (24) REF 874052 (Japan IVD, not released in the USA) was recalled by Qiagen Sciences LLC in April 27, 2022. Reason: False positive or false negative G12C (12CYS) mutation result for the KRAS Mutation Status resulting from Fla…. Check the official notice for the remedy. Verify recall #Z-0952-2022 with the FDA Devices before acting.
The recall
Qiagen Sciences LLC issued this moderate-severity FDA Devices recall-False positive or false negative G12C (12CYS) mutation result for the KRAS Mutation Status resulting from Fla….
Sourced from official FDA Devices enforcement records. Verify recall #Z-0952-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-0952-2022) was formally reported on April 27, 2022, with the manufacturer initiating the action on February 25, 2022. It is classified under Moderate severity (Class II), with a current status of Ongoing. Qiagen Sciences LLC is listed as the recalling firm, operating out of Germantown, MD. Federal records list the affected scope as 8 Kits.
The documented reason for this recall is: False positive or false negative G12C (12CYS) mutation result for the KRAS Mutation Status resulting from Flags/Warnings may invalidate the result for one or more individual mutation target of the kit. Distribution data in the federal record shows the product reached: AZ CA CT FL GA IL IN MA MN NC NY OK OR PA TN TX WV. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,861 medical devices recalls on record
Of 88,001 recalls with an agency hazard classification, 19,020 are high severity, 64,468 moderate, and 4,513 low. A further 16,157 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
8 Kits
Related Recalls
6
6 from same agency
therascreen KRAS RGQ PCR Kit (24) REF 874052 (Japan IVD, not released in the USA)
False positive or false negative G12C (12CYS) mutation result for the KRAS Mutation Status resulting from Flags/Warnings may invalidate the result for one or more individual mutation target of the kit.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Ongoing |
| Recall number | Z-0952-2022 |
| Date reported | April 27, 2022 |
| Date initiated | February 25, 2022 |
| Recalling firm | Qiagen Sciences LLC |
| Firm location | Germantown, MD |
| Affected scope | 8 Kits |
| Distribution | AZ CA CT FL GA IL IN MA MN NC NY OK OR PA TN TX WV |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Boston Scientific Corporation · 2026-07-29
Boston Scientific Corporation · 2026-07-29
AVID Medical, Inc. · 2026-07-29
Penumbra, Inc. · 2026-07-29
Alphatec Spine, Inc. · 2026-07-29
Compare this recall with FARADRIVE STEERABLE SHEATH CLEAR, used to facilitate access… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported April 27, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.